Cargando…
Human activated protein C variants in a rat model of arterial thrombosis
BACKGROUND: Activated protein C (APC) inhibits coagulation by degrading activated factor V (FVa) and factor VIII (FVIIIa), protein S (PS) functioning as a cofactor to APC. METHODS: By mutagenesis of the vitamin K-dependent Gla domain of APC, we have recently created an APC variant having enhanced an...
Autores principales: | Malm, Karl, Arnljots, Björn, Dahlbäck, Björn |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584025/ https://www.ncbi.nlm.nih.gov/pubmed/18957140 http://dx.doi.org/10.1186/1477-9560-6-16 |
Ejemplares similares
-
Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
por: Ekman, Carl, et al.
Publicado: (2011) -
Long-term outcome of lymph vessel transplantation after chronic lymphorrhea
por: Dahlbäck, Cecilia, et al.
Publicado: (2021) -
Erythrocyte-Derived Microparticles Supporting Activated Protein C-Mediated Regulation of Blood Coagulation
por: Livaja Koshiar, Ruzica, et al.
Publicado: (2014) -
A hydrophobic patch (PLVIVG; 1481–1486) in the B‐domain of factor V‐short is crucial for its synergistic TFPIα‐cofactor activity with protein S and for the formation of the FXa‐inhibitory complex comprising FV‐short, TFPIα, and protein S
por: Dahlbäck, Björn, et al.
Publicado: (2022) -
Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndrome
por: Heslet, Lars, et al.
Publicado: (2007)